New Lung Cancer Rx on the Table

Lung cancer kills more Americans than any other type of cancer, according to US Food and Drug Administration and now the agency has approved a new drug to treat lung cancer. I’m Lindsay Liepman with the latest health news. Nivolumab is a medication that treats squamous non-small cell lung cancer after chemotherapy. It is the most common type of lung cancer. Nivolumab is approved only for patients who have already had platinum-based chemotherapy. This type of chemo uses several medications derived from the element platinum to fight cancer. .